48,448
edits
Difference between revisions of "Quality"
Jump to navigation
Jump to search
→Ontario
(→Data retention standards: +CAP standard) |
|||
| (13 intermediate revisions by the same user not shown) | |||
| Line 117: | Line 117: | ||
*Grade 1: no consequence. | *Grade 1: no consequence. | ||
*Grade 2: possible consequence. | *Grade 2: possible consequence. | ||
*Grade 3: definitely a | *Grade 3: definitely a consequence. | ||
==Error reduction== | ==Error reduction== | ||
| Line 132: | Line 132: | ||
**Allow correlation with test. | **Allow correlation with test. | ||
***The interpretation may differ if the history says "screening coloscopy" versus "large cecal mass, anemia and weight loss" versus "breast cancer". | ***The interpretation may differ if the history says "screening coloscopy" versus "large cecal mass, anemia and weight loss" versus "breast cancer". | ||
*The use of algorithms to guide decisions where applicable.<ref>Kahneman D. ["Als wären wir gespalten": Der Psychologe und Nobelpreisträger Daniel Kahneman über die angeborenen Schwächen des Denkens, trügerische Erinnerungen und die irreführende Macht der Intuition]. Der Spiegel. Nr. 21. 2012. URL: [http://www.spiegel.de/spiegel/print/index-2012-21.html http://www.spiegel.de/spiegel/print/index-2012-21.html].</ref> | |||
**Remove subjectivity. | |||
**Increase objectivity, reproducibility. | |||
==Dealing with diagnostic errors== | |||
* | *Opinion is split on whether reports should be ''amended'' or ''addended'' - see ''[[sign out]]'' article. | ||
=Measures of quality= | =Measures of quality= | ||
| Line 214: | Line 217: | ||
#Counterstaining. | #Counterstaining. | ||
#Interpretation problem. | #Interpretation problem. | ||
#*Known/expected epitope cross-reactions, e.g. CMV & HSV.<ref name=pmid3029407>{{Cite journal | last1 = Balachandran | first1 = N. | last2 = Oba | first2 = DE. | last3 = Hutt-Fletcher | first3 = LM. | title = Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus. | journal = J Virol | volume = 61 | issue = 4 | pages = 1125-35 | month = Apr | year = 1987 | doi = | PMID = 3029407 | PMC = 254073 | | #*Known/expected epitope cross-reactions, e.g. [[CMV]] & [[HSV]].<ref name=pmid3029407>{{Cite journal | last1 = Balachandran | first1 = N. | last2 = Oba | first2 = DE. | last3 = Hutt-Fletcher | first3 = LM. | title = Antigenic cross-reactions among herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus. | journal = J Virol | volume = 61 | issue = 4 | pages = 1125-35 | month = Apr | year = 1987 | doi = | PMID = 3029407 | PMC = 254073 | | ||
URL = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC254073/?tool=pubmed }}</ref> | URL = http://www.ncbi.nlm.nih.gov/pmc/articles/PMC254073/?tool=pubmed }}</ref> | ||
#*Unknown/unexpected epitope cross-reactions. | #*Unknown/unexpected epitope cross-reactions. | ||
| Line 297: | Line 300: | ||
Note: | Note: | ||
*Unfortunately one has to shell | *Unfortunately one has to shell out money to get a peak at 'em. | ||
==United States of America== | ==United States of America== | ||
| Line 308: | Line 311: | ||
==Canada== | ==Canada== | ||
===Canadian immunohistochemistry quality control=== | |||
*Abbreviated ''CIQC''. | |||
*[https://ciqc.ca/Pages/default.aspx CIQC webpage (ciqc.ca)] | |||
===Ontario=== | ===Ontario=== | ||
*Quality Management Program - Laboratory Services | *[[Institute for Quality Management in Healthcare]] - previously ''Quality Management Program - Laboratory Services''. | ||
**Set-up by the ''Ontario Medical Assocation''. | **Set-up by the ''Ontario Medical Assocation''. | ||
==United Kingdom== | ==United Kingdom== | ||
| Line 322: | Line 325: | ||
*[[Critical values]]. | *[[Critical values]]. | ||
*[[CAP checklists]]. | *[[CAP checklists]]. | ||
*[[Tissue floater]]. | |||
*[[Histology artifacts]]. | |||
*[[Waffle diagnosis]]. | *[[Waffle diagnosis]]. | ||
*[[Workload measurement]]. | |||
*[[Anatomical pathology laboratory processes]]. | |||
=References= | =References= | ||